Woodcock Warns Research Apparatus Could Be Overwhelmed If Coronavirus Trials Don’t Use Master Protocols

 
• By Derrick Gingery
Coronavirus globe
CDER Director Janet Woodcock said master protocols could help assess repurposed drugs faster. • Source: Shutterstock

More from Clinical Trials

More from R&D